United Therapeutics (UTHR) Misses Q4 EPS by 21c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $555.91 +1.60%
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.51, $0.21 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $427.62 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
